PT  - JOURNAL ARTICLE
AU  - Matthew S. Rice
AU  - David C. MacDonald
TI  - Appropriate Roles of Cardiac Troponins in Evaluating Patients With Chest Pain
AID  - 10.3122/jabfm.12.3.214
DP  - 1999 May 01
TA  - The Journal of the American Board of Family
                Practice
PG  - 214--218
VI  - 12
IP  - 3
4099  - http://www.jabfm.org/content/12/3/214.short
4100  - http://www.jabfm.org/content/12/3/214.full
SO  - J Am Board Fam Med1999 May 01; 12
AB  - Background: Diagnosis of acute myocardial infarction relies upon the clinical history, interpretation of the electrocardiogram, and measurement of serum levels of cardiac enzymes. Newer biochemical markers of myocardial injury, such as cardiac troponin I and cardiac troponin T, are now being used instead of or along with the standard markers, the MB isoenzyme of creatine kinase (CK-MB) and lactate dehydrogenase. Methods: We performed a MEDLINE literature search (1987 to 1997) using the key words “troponin I,” “troponin T,” and “acute myocardial infarction.” We reviewed selected articles related to the diagnostic and prognostic usefulness of these cardiac markers in evaluating patients with suspected myocardial infarction. Results: We found that (1) troponin I is a better cardiac marker than CK-MB for myocardial infarction because it is equally sensitive yet more specific for myocardial injury; (2) troponin T is a relatively poorer cardiac marker than CK-MB because it is less sensitive and less specific for myocardial injury; and (3) both troponin I and troponin T may be used as independent prognosticators of future cardiac events. Conclusions: Troponin I is a sensitive and specific marker for myocardial injury and can be used to predict the likelihood of future cardiac events. It is not much more expensive to measure than CK-MB. Overall, troponin I is a better cardiac marker than CK-MB and should become the preferred cardiac enzyme when evaluating patients with suspected myocardial infarction.